COPD bronchodilator cardiovascular risks comparable
The risk for cardiovascular events among older patients with chronic obstructive pulmonary disease is similar if they begin treatment with long-acting ß-agonists or muscarinic antagonists, show results from a large, population-based study.
Source: MedWire News - Respiratory - Category: Respiratory Medicine Source Type: news
More News: Cardiology | Cardiovascular | Chronic Obstructive Pulmonary | Heart | Respiratory Medicine | Study